The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Ixprim 37.5 mg/325 mg film-coated tablets

37.5/325 milligram(s) Film-coated tablet

Lexon (UK) LtdPPA1097/010/001

Main Information

Trade NameIxprim 37.5 mg/325 mg film-coated tablets
Active SubstancesTramadol hydrochloride
Strength37.5/325 milligram(s)
Dosage FormFilm-coated tablet
Licence HolderLexon (UK) Ltd
Licence NumberPPA1097/010/001

Group Information

ATC CodeN02AX Other opioids
N02AX52 tramadol, combinations


Withdrawn Date03/09/2021
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable List CodeIC0077-133-014
Interchangeable List DocumentPDF of Interchangeable List
« Back